NEUES POLYPEPTID MIT AFFINITÄT ZU PD-L1

European patent · EP3368545 · In force

Register entry

Publication number
EP3368545
Application number
EP16790321
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 28, 2016
Published
Sep 5, 2018
Granted
Dec 4, 2019
Protection ends at the latest
Oct 27, 2036
Next annual fee due
Oct 31, 2026
IPC classes
C07K 14/00 (2006.01)
A61K 38/16 (2006.01)
C07K 14/435 (2006.01)
Priority
EP 15192364 30.10.2015
EP 16157154 24.02.2016
PCT application
PCT/EP2016/076040 28.10.2016
PCT publication
WO2017/072280 04.05.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  4. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  5. Feb 15, 2020

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 15.02.2020

  6. Dec 4, 2019

    Granted

    Published in Swissreg on 04.12.2019

Parties

Holder

Affibody AB

Scheeles väg 2, 171 65 Solna, SE

Agent

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventor

WAHLBERG, Elisabet

193 40 Sigtuna, SE

GUNNERIUSSON, Elin

133 36 Saltsjöbaden, SE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.